Heart development requires cardiomyocyte proliferation, coupled with morphogenic differentiation of the inner trabecular myocardium and the outer compact zone myocardium. In mouse embryos lacking the retinoic acid receptor RXRa, proliferation and morphogenesis of the compact zone fails. We demonstrated previously that epicardial cells, in response to retinoic acid, secrete an activity that promotes cell proliferation. In this study, we have investigated downstream signaling pathways that are elicited in response to this factor. We find that cells treated in culture activate PI3 kinase and Erk pathways, and that these are required for a proliferative response. In vivo, phosphorylation of Akt and GSK3b (PI3K pathway) and of Erk1/2 and p90rsk (Erk pathway) is substantially reduced in RXRa-deficient heart tissue. Neuregulin, a mitogen secreted from the endocardium which promotes cardiomyocyte proliferation and trabecular differentiation, also activates proliferation via PI3K and Erk pathways. However, the epicardial factor is not neuregulin, and does not function via the neuregulin receptor. Gene markers known to be selectively expressed in trabecular or compact myocardium in vivo are differentially activated in cell culture by treatment with neuregulin or epicardial factor, and are misexpressed in RXRa K/K heart tissue. We therefore conclude that epicardial and endocardial signals converge on common proliferative components, but diverge in downstream pathways that lead to compact vs. trabecular morphogenic differentiation.
Introduction
Organogenesis requires a spatially coordinated set of inductive signals that together result in the assembly of morphologically normal tissue. In heart development, the early ventricular chamber consists of three layers of distinct cell types. The myocardium lies in the middle, and is enveloped by endocardium to the inside, and epicardium to the outside. Ventricular development in mammals involves the growth of heart muscle, which is achieved by proliferation of cardiomyocytes, coupled with the morphogenic subdivision and assembly of the myocardium into two distinct tissue architectures: trabecular myocardium on the inside, and compact zone myocardium to the outside. Trabecular myocardium consists of bundles of cardiomyocytes (surrounded by endocardium) that project across the lumen of the ventricular chamber from the inner ventricular chamber wall, and is first evident in mouse heart development around embryonic day (E) 9.5-10.5. Compact myocardium consists of concentrically organized layers of tightly adherent cardiomyocytes that constitute the outer ventricular chamber wall. The compact zone becomes morphologically recognizable around E11.5, and continues to expand throughout gestation. It is believed that the trabecular myocardium provides most of the contractile force of the early heart, although this function is supplanted by the compact zone myocardium as the latter expands in size (Sedmera and Thomas, 1996) . Thus, mouse mutants in which trabecular formation is compromised die around E10.5, whereas those in which compact zone formation is impeded die around E14.5.
Neuregulin (glial growth factor) is expressed by the endocardium and is a required inducer of trabecular ingrowth, as mouse mutants lacking this factor or either component of its heterodimeric receptor (erbB2 and erbB4) die at E10.5 and lack trabecular formation (Gassmann et al., 1995; Lee et al., 1995; Meyer and Birchmeier, 1995) . Evidence that the epicardium promotes compact zone morphogenesis has come from mouse (Gurtner et al., 1995; Kwee et al., 1995; Yang et al., 1995) and chick (Gittenberger-de Groot et al., 2000; Perez-Pomares et al., 2002; Pennisi et al., 2003) embryos in which the epicardium is not present, and which have a hypoplastic thin ventricular chamber wall, although with mostly normal trabecular formation. We and others have proposed that the epicardium secretes a mitogenic factor that promotes compact zone formation, in a manner that is dependent upon the vitamin A metabolite retinoic acid (Chen et al., 2002; Stuckmann et al., 2003) . In mouse mutants lacking the retinoic acid receptor RXRa (Sucov et al., 1994; Kastner et al., 1994) , or in rat embryos deficient in vitamin A (Wilson and Warkany, 1949) , early trabecular formation is normal, although formation of the compact zone fails to occur, resulting in midgestation lethality in the mouse around E14.5. This phenotype is associated with a decreased proliferative rate in cardiomyocytes in the outer ventricular chamber wall (Kastner et al., 1997) , and reflects a genetic function of retinoic acid receptors in the epicardium (Chen et al., 2002) . In chick fetal heart slices in culture, treatment with a retinoic acid receptor antagonist suppresses cardiomyocyte proliferation, as does physical removal of the epicardium (Stuckmann et al., 2003) . More importantly, serum-free media conditioned by epicardial cells in culture promotes cardiomyocyte proliferation, and this activity is dependent upon retinoic acid treatment (Chen et al., 2002) .
In this study, we have investigated the manner by which cells respond to the epicardial mitogen, and have compared this response to that induced by neuregulin. While both signals are essential for heart development and morphogenesis, and while both signals act via common signal transduction components to promote cell proliferation, there is a divergence in the morphogenic consequences of inside (neuregulin) vs. outside (epicardial mitogen) signaling that may account for trabecular vs. compact zone formation.
Results
We previously demonstrated that serum-free conditioned media obtained from epicardial cells contained a mitogenic activity when applied to either primary fetal cardiomyocytes or to NIH3T3 cells. This activity induced thymidine incorporation in both cell types, and was sufficient to drive NIH3T3 cells through the cell cycle. This activity was heat-labile, suggestive of a protein or peptide (Chen et al., 2002) . We found that this activity could be concentrated on a low molecular weight cut-off filter (O3 kD), also suggestive of a protein or peptide, and removing the possibility of the mitogenic activity resulting from the presence of a small organic hormone or factor (Fig. 1A) .
Many cell types respond to mitogenic stimulation via activation of PI3 kinase and MAP kinase pathways. We therefore examined by Western blotting the phosphorylation status of the primary downstream targets of these enzymes. In fetal cardiomyocytes and in NIH3T3 cells, Akt (immediately downstream of PI3K) and Erk (downstream of raf and immediately downstream of MEK1) became rapidly phosphorylated (within 10 min) following treatment with epicardial cell conditioned media (Fig. 1B) . The other two classes of MAP kinases, JNK and p38, were not visibly phosphorylated in untreated cells or in stimulated cells (data not shown).
To confirm these results, and to evaluate the involvement of additional pathways, we treated primary fetal cardiomyocytes or NIH3T3 cells with conditioned media in the presence of a number of pathway-specific inhibitors. We found that mitogenic response (measured by thymidine incorporation) was severely blunted or eliminated in the presence of either LY294002, a specific inhibitor of PI3K, or in the presence of U0126, a specific inhibitor of Erk ( Fig. 1C and D) . However, inhibitors of p38 and JNK (SB203580 and SP600125, respectively) had little if any effect (Fig. 1D) . Inhibition of G-protein coupled pathways with pertussis toxin (Gi pathway) or with ROCK inhibitor or Y27632 (rho pathway) also had little if any effect in this assay (data not shown). We infer from these results that activation of the PI3K and of the Erk kinase pathways are required together to achieve a mitogenic response to the factor or factors present in conditioned media from epicardial cells. Rapamycin, a specific inhibitor of mTOR which is one of several effectors downstream of PI3 kinase, had a reproducible although minor inhibitory effect (data not shown), suggesting that this specific downstream pathway may not be of primary importance in the overall response of cells to the epicardial mitogen.
We have proposed that the cardiac phenotype of RXRa K/K embryos reflects the absence of epicardial signals that promote compact zone development (Chen et al., 2002) . If the in vitro results described above have relevance to fetal heart development in vivo, we predict that these pathways should be compromised in RXRa K/K embryos. Western blotting of lysates from ventricular tissue demonstrated a modest reduction in the phosphorylation status of both Akt and Erk in mutant embryos (Fig. 2) . However, we noted a substantial reduction in the phosphorylation level of GSK3b (downstream of PI3K/Akt) and p90rsk (downstream of Erk) in mutant embryos. These observations are consistent with a dimunition or loss of mitogenic signaling from the epicardium in RXRa K/K embryos, and with a consequent reduction in the proliferative rate of fetal ventricular cardiomyocytes as observed in RXRa K/K embryos. Furthermore, these results validate the tissue culture model described above as a faithful reflection of epicardialmyocardial mitogenic signaling in vivo.
In the above studies, the neuregulin receptor erbB2 was used as a loading control, as the expression of this cell surface receptor does not change in RXRa mutant tissue. In vivo, neuregulin is secreted from the endocardium and is required for ingrowth of the trabecular component of the ventricular myocardium (Gassmann et al., 1995; Lee et al., 1995; Meyer and Birchmeier, 1995) . As shown in Fig. 1C and D and in Fig. 3 , treatment of NIH3T3 cells or primary fetal cardiomyocytes with epicardial factor induced a proliferative response that was inhibited by either LY294002 or by U0126. Neuregulin also induced a proliferative response in both cell types; this response was inhibited by LY294002 or U0126 in NIH3T3 cells, and previous studies have demonstrated that cardiomyocytes also activate PI3K and Erk pathways in response to neuregulin (Baliga et al., 1999) . Furthermore, treatment with neuregulin or epicardial factor resulted in phosphorylation of Akt and Erk in either cell type in a manner that was inhibited by LY294002 and U0126, respectively. . Cells were serum-deprived prior to replacement of media with serum free media (SF), 10% fetal bovine serum, or with serum-free epicardial cell conditioned media (ECM). ECM was also fractionated into a low molecular weight filtrate (!3 k) and a concentrated retained fraction (O3 k), which was diluted back to original concentration in serum-free media. Proliferative response was measured as CPM of incorporated 3 H-thymidine. (B) Epicardial factor induces activation of PI3K and Erk pathways. Cell lysates from primary fetal cardiomyocytes (left) or NIH3T3 cells (right) were blotted and probed with antibodies against phosphorylated Akt, total Akt, phosphorylated Erk, and total Erk. (C) Proliferative response in primary fetal cardiomyocytes is dependent on PI3K and Erk pathways. Treatment of cells with LY294002 (a specific inhibitor of PI3K) or U0126 (a specific inhibitor of Erk kinase) abolishes the response of cells to epicardial cell conditioned media in a dose dependent manner. (D) Proliferative response in NIH3T3 cells in the presence of inhibitors. Response is abolished by LY294002 and by U0126 (left), but not by SB203580 or SP600125 (inhibitors of p38 MAPK and JunK, respectively; at right).
The neuregulin receptors (erbB2 and erbB4) are members of the receptor tyrosine kinase family. We hypothesized that the epicardial factor might also work through a related receptor. Treatment of NIH3T3 cells with epicardial cell conditioned media resulted in the appearance of an approx. 180 kD band when visualized by Western blotting with an anti-phosphotyrosine antibody (Fig. 4A ). This protein was present in the plasma membrane fraction (Fig. 4B) , suggesting that it might be a cell surface receptor. Treatment of cells with neuregulin results in the phosphorylation of erbB2 (Fig. 4C) . The sizes of phospho-erbB2 and of the protein phosphorylated in response to epicardial factor are both approx. 180 kD; however, by immunoprecipitation followed by Western immunoblotting, it is clear that the high molecular weight protein that is phosphorylated in response to epicardial cell conditioned media is not erbB2 (Fig. 4C) . Therefore, neuregulin is not responsible for the mitogenic activity of epicardial cell conditioned media, and the response to this factor does not involve activation of the neuregulin receptor erbB2.
Our results suggested that signals from the epicardium and endocardium both converge on the same signal transduction pathways (e.g. PI3K and Erk) to induce cardiomyocyte proliferation. To address whether these signals have differing consequences in ventricular tissue morphogenesis, we surveyed the expression of genes that are known to be selectively expressed in either compact zone myocardium or in trabecular myocardium. VCAM-1 is a cell adhesion molecule that is expressed selectively in the compact zone of midgestation embryos (Kwee et al., 1995) , whereas BMP10 is a secreted factor expressed in the trabecular myocardium of the embryonic ventricle . In primary cardiomyocyte cell culture, VCAM-1 expression was specifically upregulated by epicardial factor, whereas expression of the trabecular marker BMP10 was specifically upregulated by neuregulin (Fig. 5B) . VCAM-1 was similarly upregulated by epicardial factor in NIH3T3 cells ( Fig. 5A ; BMP10 is not expressed in this cell line). To extend these observations to the developing heart, we evaluated the expression of these genes in ventricular tissue from midgestation embryos that were either control or deficient for RXRa. Indeed, VCAM-1 Fig. 2 . Activation of PI3K and MAPK pathway components is suppressed in RXRa K/K heart tissue. Ventricular tissue from individual E13.5 littermate embryos of the genotypes indicated was homogenized and subject to Western blotting using antibodies against phospho-specific and total Akt, GSK3b, Erk, and pp90rsk. An antibody against the neuregulin receptor erbB2 was also used as a loading control. expression was reduced in RXRa mutant hearts, whereas expression of BMP10 was unchanged (Fig. 5C ). These observations suggest that expression of VCAM-1 and BMP10 is regulated by signals from the epicardium and endocardium, respectively. Furthermore, we infer that perturbation of epicardial signaling as occurs in RXRa
hearts results in morphogenic defects as well as proliferative defects in vivo, although without affecting endocardial (neuregulin) signaling.
Discussion
It is a general developmental principle that embryonic cells of different lineage origin interact to effect further morphogenesis. In heart development, the myocardium induces an epithelial-mesenchymal transformation in specific parts of the endocardium to create cushion tissue that will become remodeled into the atrioventricular and outflow tract valves (Eisenberg and Markwald, 1995) , and induces an epithelial-mesenchymal transformation in the epicardium to yield cells that become the endothelial and smooth muscle cells of the coronary arteries and the cardiac fibroblast population (Morabito et al., 2001 ). The factors secreted by the myocardium that induce these events include TGFb and FGF, respectively (Brown et al., 1996; Morabito et al., 2001) . Reciprocally, the myocardium is instructed by the epicardium to form the compact zone of the outer ventricular chamber wall (Chen et al., 2002; Stuckmann et al., 2003) , and forms trabecular myocardium in response to neuregulin (Gassmann et al., 1995; Lee et al., 1995; Meyer and Birchmeier, 1995) and perhaps additional factors from the endocardium. Thus, all of the four possible interactions between adjacent layers of the developing heart have important developmental consequences, and all are mediated by secreted protein factors.
Although we do not yet know the identity of the mitogen that is produced by epicardial cells, several aspects of its action are now more clear. First, cells must activate both the PI3 kinase and MAP (Erk) kinase pathways in order to respond to this factor. Our demonstration that downstream components of these pathways are hypophosphorylated in ventricular tissue of RXRa K/K embryos lends considerable credence to the model that these same pathways are required for normal heart development in vivo. Interestingly, the proliferative responses to neuregulin and to the epicardial mitogen appear to be identical, at least insofar as their utilization of the PI3K and Erk pathways. This would in fact make sense, if these are the primary intracellular pathways through which fetal cardiomyocytes regulate their cell cycle, regardless of the initial sources of proliferative signals.
Although it is possible that more than one factor is secreted from the epicardium-e.g. one which is proliferative and another which is morphogenic-our current evidence suggests this is not the case. Through partial biochemical purification (data not shown), the ability to induce thymidine incorporation (as in Fig. 1 ), activation of PI3 kinase and Erk (Fig. 1) , and induction of VCAM-1 (as in Fig. 5 ) all co-purify. We also note for comparison that mitogenic and morphogenic consequences are both elicited in response to the single factor neuregulin. In general, downstream effects of extracellular signals are transduced by multiple specific intracellular adaptors or kinases recruited to the relevant receptors. Presumably, some of these mediators are commonly utilized for the endocardial and epicardial response, whereas others are unique and lead to divergent effects.
We suspect, although cannot yet prove, that the epicardial mitogen is a ligand for a cell surface receptor tyrosine kinase. We previously showed that genistein, a selective inhibitor of all tyrosine kinases, is able to block the proliferative response to the epicardial mitogen in cell culture (Chen et al., 2002) , and in the present study we observed an approx. 180 kD membrane-associated protein that becomes tyrosine phosphorylated in response to this mitogen. Additionally, phosphorylation of this protein is not blocked by pretreatment with the kinase inhibitors LY294002 or U0126 (data not shown). It remains possible, however, that this protein species is an intermediate component of the response, or even one that is not required for response at all, and that the receptor of the epicardial Following treatment with ECM or with neuregulin (NRG), whole cell lysates were immunoblotted for phosphotyrosine or erbB2, or were first immunoprecipitated with either antibody followed by immunoblotting for the other; the arrow points to the approx. 180 kD protein that is phosphorylated by both treatments.
signal is of a class that is other than a receptor tyrosine kinase.
The most important concept to emerge from our study is the clarification of the roles of mitogenic signaling in heart development and in ventricular chamber morphogenesis. Cardiomyocyte proliferation is required to provide the material which becomes assembled into the trabecular or compact muscle of the growing fetal heart. Neuregulin, secreted from the endocardium, induces proliferation as well as trabecular ingrowth from the inner ventricular chamber wall. We hypothesize that myocardial cells facing outwards towards the epicardium are normally exposed to a parallel signal that induces proliferation as well as the assembly of these myocytes into a compact morphology. Accordingly, the myocardium can be considered naïve, and subject to whichever inductive signal is received most strongly. Importantly, the epicardial signal and the endocardial signal converge to induce proliferation, and yet diverge to induce compact or trabecular morphologies. This model accounts for the general requirement for cardiomyocyte proliferation during heart development, as well as for the organization of the ventricular chamber into morphologically distinct trabecular and compact zone tissue. In RXRa mutant embryos, where the production of the outside signal is compromised, trabecular formation occurs normally, although formation and expansion of the outer compact zone myocardium fails to occur.
The pathways that result in trabecular or compact zone morphogenic differentiation are essentially unknown. In this study, we exploited the expression of genes that are differentially expressed in trabecular vs. compact muscle in vivo as markers of these fates in vitro. Indeed, we found that BMP10 is specifically induced by neuregulin, and VCAM-1 by epicardial factor, in primary fetal cardiomyocytes (and VCAM-1 also in NIH3T3 cells). VCAM-1 is a receptor for integrins expressed by epicardial cells that allow the adherence of the epicardium to the myocardium, and VCAM-1 knockouts die in midgestation with an absent epicardium and consequently thin myocardial wall (Gurtner et al., 1995; Kwee et al., 1995) . Although VCAM-1 expression is reduced in RXRa K/K ventricular tissue, this is only by approx. half, and the epicardium is present in 
RXRa
K/K embryos as well as in VCAM-1 heterozygotes. Presumably, the assembly of cardiomyocytes into the compact organization of the ventricular chamber wall depends on cell adhesion molecules. If VCAM-1 has any such role (in addition to its known role in promoting epicardial adherence), the regulation of its expression by epicardial signaling is not obligate, as VCAM-1 heterozygotes are not known to suffer from any failure in compact zone organization. Rather than being functionally relevant to the etiology of the ventricular chamber phenotype of RXRa K/K embryos, the misexpression of VCAM-1 is probably more important as a marker of altered gene expression that characterizes this phenotype, and of the presumptive pathways that diverge from those stimulated by endocardial signaling.
BMP10 is expressed selectively in trabecular myocardium and in fact is required for trabecular development in vivo. Interestingly, neuregulin is not able to rescue BMP10-deficient heart morphogenesis, indicating that BMP10 is either downstream of neuregulin or irrelevant to neuregulin signaling pathways (Baliga et al., 1999) . Our results indicate that neuregulin induces BMP10 expression, at least in primary fetal cardiomyocytes (Fig. 5) ; the trabecularrestricted expression of BMP10 may therefore reflect simply the trabecular-restricted expression of neuregulin.
In addition to BMP10 and VCAM-1, a number of genes are known to be preferentially expressed in either the trabecular or compact zone myocardium. ANF is a trabecular marker (Christoffels et al., 2000) ; we found that ANF expression in primary cardiomyocytes in culture was specifically induced by neuregulin but not by epicardial factor (data not shown), suggesting that like BMP10 it is regulated by endocardial signaling. Unexpectedly, ANF expression was modestly reduced in ventricular tissue from RXRa-deficient embryos (data not shown). Presumably, this reduction does not reflect a direct perturbation of neuregulin signaling in RXRa mutants, but rather some indirect alteration in any of the multiple known pathways that are known to regulate ANF expression (Small and Krieg, 2002) . Members of the FGF ligand and receptor families are among those that are selectively expressed in the compact zone (Morabito et al., 2001; Pennisi et al., 2003) . In our analysis, expression of FGF2 and FGFR1 was not regulated by neuregulin or epicardial cell conditioned media in cell culture (data not shown; we did not examine FGF1). Interestingly, a recent study in chick embryos has shown that absence of the epicardium in otherwise intact hearts does not alter transmural (i.e. compact zone specific) expression pattern of FGF1, FGF2, and FGFR1 (Pennisi et al., 2003) . Thus, signals from the epicardium are clearly not solely responsible for establishing compact zone vs. trabecular gene expression patterns. Our positive results with VCAM-1 and BMP10 suggest that these genes may be more immediately responsive to epicardial and endocardial signals, respectively. BMP10 is known to be both upstream and downstream of Nkx2.5 function Pashmforoush et al., 2004) , and is also upregulated in FKBP12 mutant hearts . VCAM-1 is regulated by a variety of cytokines such as TNFa and IL4, in part via a NFkB pathway (Bergese et al., 1995) . Our current efforts include the identification of regulatory mechanisms that control expression of VCAM-1 and BMP10 in response to epicardial or endocardial factors. This approach may reveal divergent signal transduction pathways that selectively promote expression of these markers; these same pathways may also be involved in the more general aspects of trabecular vs. compact zone morphogenesis in the ventricular chamber in vivo.
Experimental procedures
Cell culture. NIH3T3 cells were maintained in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal calf serum (FCS). Primary cultures of chick or mouse cardiomyocytes were prepared from ventricular heart tissue of chick embryos (E7) or ICR mouse embryos (E13.5) by collagenase/pancreatin digestion followed by purification on a Percoll gradient as previously described (Chen et al., 2002) . Cardiomyocytes were obtained with O95% purity as assessed by MF20 sarcomeric actin immunostaining. Following purification, cardiomyocytes were plated on gelatin-coated dishes in 4:1 DMEM/M199, 5% FCS, 10% horse serum. Media was changed to serumfree DMEM for 24 h before experimental stimulation. Thymidine incorporation assays were as previously described (Chen et al., 2002) ; inhibitors were added to cell cultures 1 h prior to the addition of conditioned media or other factors and included for the duration of treatment. All data points represent at least quadruplicate samples for both cell types. To prepare epicardial cell conditioned media (ECM), rat epicardial mesothelial cells (Eid et al., 1992) or a stable subline of primary fetal mouse epicardial cells (Chen et al., 2002) were grown in DMEM supplemented with 20% FCS until reaching confluence, then switched to serum-free DMEM for 24 h. The media was then replaced with fresh DMEM including all-trans retinoic acid (1 mM) and collected after 48 h. Concentration of ECM was achieved using a 3 kD cut-off filter in an Amicon ultrafiltration cell apparatus, and was diluted with serum-free DMEM for use. Recombinant human neuregulin (NRG1-b1) was purchased from R & D.
Western blot analysis and immunoprecipitation. Following serum starvation for 24 h, cells were stimulated with epicardial cell conditioned media or with neuregulin for 10 min; if used, inhibitors were added as a pretreatment to the cells 30 min before stimulation. Cells were then washed with ice-cold PBS, and lysed with lysis buffer (1% Nonidet P-40, 20 mM Tris, pH 8.0, 137 mM NaCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10% glycerol, 10 mM EDTA, 2 mM Na 3 VO 4 , 1 mM DTT, 1 mM PMSF, 10 mM NaF, 10 mM Na pyrophosphate, 1 mg/ml aprotinin, and 1 mg/ml leupeptin). Following rocking for 30 min at 4 8C, lysates were centrifuged at 15,000!g for 20 min and the supernatant was used for protein measurement. Embryonic ventricular heart tissue was isolated and homogenized in lysis buffer as above. For isolation of membrane proteins, NIH3T3 cells were serum-starved for 24 h, then stimulated with agents for 10 min. Cells were collected and homogenized in a homogenization buffer (20 mM Hepes, pH 7.4, 250 mM sucrose, 1 mM EDTA, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin). The total homogenates were centrifuged at 19,000!g for 20 min. The supernatant was used as the cytoplasmic fraction; the pellet was rehomogenized in 5 ml of buffer A (20 mM Hepes, pH 7.4, 1 mM EDTA, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin) and applied onto 20 ml of 1.12 M sucrose cushion in buffer A followed by centrifugation at 100,000!g for 1 h. The flocculent materials (w5 ml) were collected from the interphase and centrifuged at 50,000 for 30 min. The resulting pellet (plasma membrane fraction) was resuspended in 0.2 ml buffer A. For Western blot analysis, samples were subjected to SDS-PAGE, and transferred onto Immuno-Blot PVDF membranes (BioRad). The membranes were probed with antibodies from Upstate (phosphotyrosine, erbB2), Cell Signaling (Akt, pAkt, pGSK3b, pErk1/2, pp90rsk) and B and D (GSK3b), and Santa Cruz (Erk1/2, p90rsk). After secondary incubation with an HRP-conjugated antibody, signal was detected using enhanced chemiluminescence (ECL) reagents (Pierce). For immunoprecipitation, cell lysates (500 mg protein) were incubated with anti-erbB2 (2 mg) or anti-PY (2 mg) overnight at 4 8C, and then incubated with protein G agarose (20 ml of 50% slurry; Upstate) for 2 h. After washing with lysis buffer three times, the mixtures were spun for 2 min and the precipitates used for Western blot analysis.
Quantitative RNA analysis. NIH3T3 cells and mouse cardiomyocytes were plated and serum-starved 24 h before stimulation. Total RNA from cells and ventricular heart tissue was isolated using acid phenol-guanidinium thiocyanate-chloroform extraction, followed by reverse transcription using random decamer primers. Real time PCR was performed using a BioRad iCycler IQ thermocycler with SYBR green fluorescence detection. 18S rRNA was used as an internal reference to normalize results.
